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Abstract
Pectin, a natural ionic polysaccharide found in the cell wall of terrestrial plants 
undergoes chain–chain association to form hydrogels upon addition of divalent  
cations. Based on its degree of esterification, pectin has been classified into two 
main types. The high methoxyl pectin with a degree of esterification greater than 
50%, which is mainly used for its thickening and gelling properties and the low 
methoxyl pectin, which is widely used for its low sugar-content in jams, both 
applications being in the food industry. Pectin is mostly derived from citrus fruit 
peels, but can also be found in other plants such as waterleaf leaves, cocoa husk, 
and potato pulps. Pectin has been used as an excipient in pharmaceutical formula-
tions for various functions. This chapter will focus on the various applications to 
which pectin has been used in the pharmaceutical industry.
Keywords: Pectin, Degree of Esterification, Drug Delivery, Polymer Matrix, 
Excipients
1. Introduction
In the pharmaceutical industry, plants and plant products are continually used 
as sources of drugs and excipients. In particular, plant-derived polymers have con-
tributed significant roles in drug delivery systems where they function as excipients 
[1]. Excipients refer to the non-pharmacological ingredients that are required 
to convert the Active Pharmaceutical Ingredient (API) into a dosage form. The 
International Pharmaceutical Excipients Council (IPEC, 1995) defines excipients as 
all substances contained in a dosage form other than the active substance or finished 
dosage form, which have been appropriately evaluated for safety and are included in 
a drug delivery system [2]. Excipients are included in drug delivery systems to assist 
in processing during manufacture, protect, support, enhance stability, bioavail-
ability and patient acceptability, help in product identification, or enhance any 
other aspects of the drug delivery system’s overall safety and effectiveness during 
use or storage [2–4]. Far from being just a random combination of ingredients, a 
pharmaceutical formulation is a well-rationalized formulation designed to satisfy 
quality and performance. Excipients are essential in the drug development process, 
as well as the formulation and administration of stable dosage forms [2]. Excipients 
are required in drug formulations to guarantee the potency, safety, predictability 
and reproducibility of the release of the API as well as its palatability and suitability 
for the patients [3].
The interest in excipients of plant origin over semi-synthetic or synthetic 
excipients is not far-fetched: low toxicity, relative abundance, cost-effectiveness 
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and non-irritant nature make them preferable to others sources [5]. Plant-based 
polymeric excipients can be used in different pharmaceutical formulations where 
they act as diluents or bulking agents, thickeners, binders, disintegrants, suspend-
ing agents, emulsifiers, film formers, matrix formers, release modifiers, sweeteners 
and mucoadhesive polymers [6–9]. These natural polymers would have to fulfill the 
requirements of an ideal excipient to be successful candidates for use as excipients 
in various formulations for pharmaceutical use. The requirements for an ideal 
excipient includes being pharmacologically inert, non-toxic and non-irritant as well 
as being non-reactive with drug or with other substances present in the formula-
tion and the packaging. In addition, they must be easy to handle, cost-effective and 
readily available for the sustainable manufacture of the pharmaceutical product. 
Numerous plant polymers fulfill many of these requirements and have found 
application in pharmaceutical formulations. These include Inulin; a polysaccharide 
obtained from plant sources like; onion, garlic, artichoke and chicory, starches 
which are polymeric carbohydrates with large glucose units joined by glycosidic 
bonds, gums, and mucilage such as: acacia gum, tragacanth gum, locust bean gum, 
okra mucilage, seaweed polysaccharides which include carrageenan, agar and 
alginates, microbial polysaccharides such as: xanthan gum and pullulan obtained 
by the fermentation of carbohydrate products by specific bacteria or fungus, and 
polysaccharides of the plant cell wall with cellulose, hemicelluloses, pectin being 
the main polymers of this group [10–16].
Pectin, a structural heteropolysaccharide, is considered the second most abun-
dant component of the cell wall of all terrestrial plants [17, 18]. It is a hydrophilic 
polymer that is biodegradable, biocompatible and non-toxic, making it a good 
biomaterial for packaging, coating and various pharmaceutical applications. Pectin 
is normally produced during the initial stages of growth of the primary cell wall and 
constitutes about one-third of the dry substance of the cell wall of some monocoty-
ledonous and dicotyledonous plants [19]. A white to light brown powder, pectin is 
found in numerous fruits and vegetables. The main raw materials for pectin produc-
tion are dried citrus peels or apple pomace, both by-products of juice production 
that are often discarded as waste. Alternative sources of pectin extraction include 
sugar beet waste from sugar manufacturing, mango waste from mango canning 
factories and sunflower seeds used for extracting edible oil, waterleaf leaves, cocoa 
husk, and potato pulps [20–23].
Pectin is the methylated ester of polygalacturonic acid which contains 1, 
4-linked α-D-galacturonic acid residues and a variety of neutral sugars like arabi-
nose, galactose, rhamnose and lesser amounts of other sugars [24, 25]. It can be 
classified into different types based on the degree of esterification or the number 
of methoxy groups that substitutes the carboxylic acid moiety on the galacturonic 
acid residues [26]. The degree of esterification influences the gelation mechanism, 
processing conditions and properties of the pectin [18, 27]. High methoxyl pectin 
is primarily used for gelation and has a degree of esterification greater than 50%. 
It requires a large amount of sugar and is acid-sensitive. Because of hydrogen 
bonding and hydrophobic interactions between the pectin chains, high methoxyl 
pectin forms a gel at low pH and a high concentration of soluble particles [28]. Low 
methoxyl pectin has a degree of esterification of less than 50% and is widely used 
in the food industry to form low sugar jams since it does not require a large amount 
of sugar for gelation. It shows less sensitivity toward acidity and requires Ca2+ ions 
to form gel [29]. Low methoxyl pectin is generally formed by the de-esterification 
of high methoxy pectin using acids, alkali, pectin methylesterase and ammonia in 
alcohol or concentrated aqueous ammonia. Monovalent cation i.e. alkali metal salts 
of pectin is normally soluble in water while di- and trivalent cations are partially 
or completely insoluble in water. When dissolved, pectin decomposes rapidly by 
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de-esterification or depolymerization. The rate of decomposition depends on the 
pH and temperature of the solution. The maximum stability of pectin is at pH 4 
[30]. Low pH and high temperature increase the rate of degradation due to hydro-
lysis of the glycosidic linkage. At alkaline pH, pectin is rapidly de-esterified and 
degraded even at room temperature [31].
In this Chapter, the sections that follow would review in detail, some important 
pharmaceutical applications of pectin and possible modifications to enhance the 
future uses of pectin in pharmaceutical formulations.
2. Pharmaceutical uses of pectin
2.1 Drug delivery systems
The polymer pectin has been put to several uses since its discovery over 
200 years ago. Though its major application has been in the food industry where 
it has been used as a gelling agent, emulsifier, stabilizer, thickener, and more 
recently as a food packaging material, where they as used as edible films on fruits 
and vegetables etc. The most important use of pectin is based on its ability to form 
gels, hence its potential as an excipient; pectin has been used as a binding agent 
[32, 33] in tablets, carrier for drug delivery to the gastrointestinal tract from matrix 
tablets, and as a controlled-release matrix in tablet formulations [34–36]. It has 
also been used as a sustained release drug delivery system in gel beads prepared by 
the ionotropic gelation method [19, 37, 38], colon-specific drug delivery vehicle 
[39], and film-coated dosage forms. Gel formation is caused by hydrogen bonding 
between free carboxyl groups on the pectin molecules and between the hydroxyl 
groups of neighboring molecules [40]. Most of the unesterified carboxyl groups in 
pectin occur as partially ionized salts in a neutral or very slightly acid dispersion 
of pectin molecules. [41]. Those that are ionized produce a negative charge on the 
molecule, which together with the hydroxyl groups causes it to attract layers of water 
[38]. Because of their negative charge, the repulsive forces between these groups can 
be strong enough to preclude the creation of a pectin network. When acid is added, 
the carboxyl ions are converted to mostly unionized carboxylic acid groups [38]. 
The attraction between pectin and water molecules is lowered by a reduction in the 
number of negative charges, which also lowers the forces of repulsion between pec-
tin molecules. Sugar further decreases the hydration of the pectin by competing for 
water [41]. These conditions decrease the ability of pectin to stay dispersed. When 
cooled, the unstable dispersion of less hydrated pectin forms a gel, a continuous 
network of pectin holding the aqueous solution. High methoxyl pectin produces 
gels with sugar and acid. Unlike Low methoxyl pectin, high methoxyl pectin does 
not contain sufficient acid groups to gel or precipitate with calcium ions, although 
other ions such as aluminum or copper cause precipitation under certain condi-
tions [25]. The degree of esterification (DE) affects the rate at which gel formation 
takes place [38]. A higher DE causes a more rapid setting. Slow-set pectins (with 
DE 58–65%) gel at lower soluble solids and greater levels than rapid-set pectins 
(DE > 72 per cent). Low methoxyl pectins require the presence of divalent cations 
(usually calcium) for proper gel formation [38].
2.2 Bioadhesive systems
The ability of pectin to absorb water, swell and form bioadhesive bonds with 
biological tissue has found application in the preparation of mucoadhesive formu-
lations such as patches [42]. Pectin has also been found useful as a demulcent in 
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Brand Name Ingredients/strength Dosage form Manufacturer
Berry Breezer Throat 
Drop
7 mg/1 Lozenge Topco Associates 
USA
Burts Bees Throat 
Soothing
10.5 mg/1 Lozenge L. Perrigo 
Company USA
CVS Clean Label Throat 
Relief Pops
12 mg/1 Lozenge CVS Pharmacy 
USA
Grape Throat Relief 
Lollipop
10 mg/1 Lozenge Topco Associates 
USA
Little Remedies Sore 
Throat Pops
5.4 mg/1 Lozenge Medtech 
Products Inc. 
USA
Ludens Assorted Flavors 2.8 mg/1 Lozenge Prestige Brands 
Holdings, Inc. 
USA
Sundown Honey Soothers 
Lollipops
0.1 g/100 g Lozenge The Nature’s 
Bounty Company 
USA
Throat Coat Lemon 
Ginger Echinacea
5 mg/4.2 g Lozenge Traditional 
Medicinals, Inc. 
USA
Axcel Kaopec Suspension Pectin (20 mg/5ml) + Kaolin  
(1 g/5ml)
Suspension Kotra Pharma 
(M) Sdn. Bhd.
Benylin DM With Pectin 
Freezer Pops
Pectin (150 mg/unit) + 
Dextromethorphan hydrobromide 
(7.5 mg/unit)





Cepacol Sore Throat and 
Coating
Pectin (5 mg/1) + Benzocaine  
(15 mg/1)
Lozenge Reckitt Benckiser
Cepacol Sore Throat Plus 
Coating




Diaret Liq Pectin (150 mg/30 mL) + Kaolin 
(3.078 g/30 mL)
Liquid Produits Francais 
Labs Inc. Canada
Diaret Tab Pectin (45 mg/tab) + Aluminum 
hydroxide (70 mg/tab) + 
Attapulgite (350 mg/tab) + Zinc 
phenolsulfonate (30 mg/tab)
Tablet Produits Francais 
Labs Inc. Canada
Diban Cap Pectin (71.4 mg) + Atropine sulfate 




Capsule Wyeth Ayerst 
Canada Inc.




Organix Complete Pectin (1.7 mg/1) + Levomenthol 
(2.5 mg/1)
Lozenge Pro Phase Labs, 
Inc.
Herbon Berry Buddies Pectin (10 mg/1) + Echinacea 
purpurea (50 mg/1)




Some commercial drug products containing pectin.
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throat lozenges where it gives temporary relief for minor discomfort and protects 
irritated areas in sore mouth and sore throat [43]. The antihemorrhagic effect of 
pectin has also been utilized in wound healing as medical adhesives [44].
2.3 Disperse systems
Pectin has been shown to have foam stabilizing and emulsification potential 
since the protein and hydrophobic acetyl groups of pectin can act as anchors on the 
oil particle surface, thus decreasing the surface tension [45]. Other areas of use have 
been as an emulsifier in oil: water emulsions [46, 47], and as a viscosity enhancer in 
lipid digests [48]. Pectin slows gastric transit thus helps control energy intake and 
hence its use by weight-watchers, since the large water-binding capacity of pectin 
reduces contact between intestinal enzymes and food, thus prolonging gastric 
emptying half-life, allowing a marked reduction in quantity and frequency of eating 
[49]. Furthermore, its interaction with polyphenolic compounds leads to systemic 
anti-inflammation [50].
2.4 Health benefits
In the pharmaceutical industry, pectin has been used both for its health ben-
efits and as an excipient. Pectin as an active agent was formerly used in diarrhea 
mixtures, in conjunction with kaolin and sometimes bismuth compounds, and in 
wound dusting powders and ulcer dressings where pectin appears to have some 
specific activity in promoting healing [25]. It has been found to have certain health 
benefits such as reducing cancer development, lowering blood cholesterol and 
blood glucose level through the different domains of the pectin structure, and 
stimulating the immune response [51–55].
2.5 Other applications
Pectin’s application has spread to water treatment where it is used as a biosorbent 
to remove heavy metals [47] and in urinary excretion of toxic minerals such as lead, 
cadmium, strontium, or arsenic [56–58]. In cosmetics, it is used as a plasticizer, 
texturizer and adhesive [59], and in biomedical applications, where it is used as a 
biomaterial ink to fabricate patient-specific scaffolds when cross-linked with 3-gly-
cidyloxypropyl trimethoxysilane (GPTMS) [60]. Some examples of drug products 
that contain pectin are presented in Table 1.
3. Material properties of pectin
Pectin is an important biomaterial that has numerous pharmaceutical applica-
tions. Its application, however, largely depends on its material properties such as 
degree of esterification (DE), degree of blockiness (DB), ash value and solubility. 
This section will focus on these properties and how each affects the application of 
pectin pharmaceutically.
3.1 Degree of esterification
The DE of pectin is the ratio of esterified D-galacturonic acid (GalA) groups 
to total GalA groups [34, 61]. Depending on the species, tissue, and maturity 
of the plant, the DE can have a wide range. In general, the structure of pectin is 
mostly composed of homogalacturonan (HG), regions (partially 6-methylated and 
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2- and/or 3-acetylated poly-α(1–4)-D-galacturonic acid residues), alternating with 
rhamnogalacturonan I (RG-I), regions (branched α(1–2)-L-rhamnosyl-α(1–4)-D-
galacturonosyl chains substituted with side chains of mainly α-L-arabinofuranose 
and α-D-galactopyranose) [18, 62]. The interconnection of HG “smooth” (responsi-
ble for the gelling capability) and RG-I “hairy” (play a gel-stabilizing role) regions, 
in relative proportions determine the flexibility and rheological properties of the 
polymer in solution [63, 64]. The gelling mechanism of pectin is dictated by its 
degree of esterification (total methoxyl content) [65]. Pectin based on the DE can 
be classified as high methoxyl (HM) pectin with DE > 50% or low methoxyl (LM) 
pectin DE < 50%, which are either the conventionally demethylated or the amidated 
molecule [66–68]. The two groups of pectin gel by different mechanisms. To form 
gels, high methoxyl pectin requires a minimum amount of soluble solids and a pH 
of around 3.0.
HM pectins are generally hot water-soluble, thermally reversible, and often 
contain dextrose (a dispersion agent) to prevent lumping. Conversely, LM pectins 
produce gels independent of sugar content, are less sensitive to pH compared to the 
HM pectins, and require the presence of a controlled amount of calcium or other 
divalent cations for gelation [41].
The specific application to which pectin will be put is a function of its gelling behav-
ior, which is dependent on its DE, the monosaccharide content (HG), and the spatial 
disposition of the cross-linking blocks (RG) [69]. While HM pectins have been used 
in tablet formulations as a binder, controlled-release matrix and taste masker through 
complexation with bitter molecules, the LM pectins have been used as sustained-
release matrices in microspheres produced by ionotropic gelation [19, 53, 69].
3.2 Degree of blockiness
Pectin, an anionic cell wall polysaccharide through its non-methyl esterified 
galacturonic acid units, interacts with divalent cations [40, 47]. At pH values above 
the pKa of pectin (2.8 to 4.1), non-methyl esterified GalA residues can be negatively 
charged, giving pectin the ability to interact with cations [34, 70]. Thus, the lower 
the DE of pectin, the higher the number of non-methyl esterified GalA residues 
present, the higher the cation-binding capacity. Due to LM pectin’s higher number 
of negatively chargeable carboxyl groups (non-methyl esterified carboxyl groups) 
compared to HM pectin, it exhibits a higher charge density, further showing that 
the cation-binding capacity of pectin increases with decreasing DE [40, 70, 71]. 
Studies have shown that regardless of the method used, a stronger and higher 
bound interaction occurs between pectin with decreasing DE and cations (Fe2+, 
Zn2+, or Ca2+) [47]. Furthermore, the DE and the intramolecular distribution of the 
non-methyl esterified carboxyl groups within the pectin determine pectin’s anionic 
nature and associated functionality [72, 73]. Interestingly, less described in the 
literature is the influence of the distribution pattern of non-methyl esterified GalA 
units on the cation-binding capacity of pectin compared to DE [47].
Daas et al. first quantified the relative occurrence of blocks of non-methyl 
esterified GalA units within a pectin chain as the degree of blockiness, DB [47, 74]. 
Apart from the DB, the absolute number of non-methyl esterified GalA units pres-
ent in blocks can be expressed as the absolute degree of blockiness (DBabs). Both 
parameters (DB and DBabs) were established by exhaustive enzymatic degradation 
of pectin using endo-polygalacturonase (endo-PG) of Kluyveromyces fragilis, which 
required at least four consecutive non-methyl esterified GalA units to hydrolyze the 
linkage between two non-methyl esterified GalA units [70]. The DB is the propor-
tion of galacturonic acid units (mono-, di-, and tri-) released by the enzyme to the 
total amount of non-methyl esterified GalA units, while DBabs is the number of 
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GalA oligomers released in the endo-PG digest to the total number of GalA units in 
the pectin polymer, without adjustment of the DE [47, 74, 75]. Thus, to characterize 
the presence of blocks of non-methyl esterified GalA units, these parameters (DB 
and DBabs) are used [70]. For most of the cations (divalent cations), the binding 
between them and pectin is known to follow the egg-box model [47]. The egg-box 
model of ´binding was mainly described for pectin-Ca2+ binding but assumed to be 
applicable for interaction between pectin and other divalent cations [76]. However, 
Assifaoui et al. [77] reported that the egg-box model was more appropriate for Zn2+ 
binding than Ca2+ as they found that Zn2+ interacts with both carboxyl and hydroxyl 
groups, comparable to the egg-box model, whereas Ca2+ binds only via carboxyl 
groups [40]. This egg-box model yields stronger gels [78, 79].
Applications to which a high DB is required would thus mean high cation-
binding capacity and hence the use of LM pectins and the converse is true.
3.3 Ash value
The ash content of pectin is a valuable tool in determining the purity as well as 
the gel-forming capability of the polymer. The ash content of pectin has been found 
to increase as the yield of pectin decreases [80]. High levels of ash in pectin may be 
caused by elevated concentrations of negatively charged carboxylic groups of pectin 
and the counterions in solution during pectin precipitation [41]. However, for gel 
formation, low ash content (≤ 10%) is a more favorable criterion as this will aid in 
determining the applicability of the polymer [47, 81, 80]. Ash content along with the 
anhydrouronic acid value of pectin has also been used to determine its purity [82, 83].
3.4 Solubility
Pectins are soluble in pure water. The solubility appears to depend on the 
valency of the cation salt; monovalent cation salts of pectin and pectic acids are 
usually soluble in water, while the di- and trivalent cation salts are weakly soluble 
or insoluble in water. Dry powdered pectin hydrates very rapidly when added 
to water, but tends to form clumps. These clumps are semidry packets of pectin 
within a highly hydrated outer coating. Dry mixing the powder with water-soluble 
carrier material can prevent the formation of clumps or by the use of specially 
treated pectin that has improved dispersibility [20, 83]. Studies have shown that 
pectin extracted with distilled water showed a high yield and low ash content when 
compared to other solvents [79]. High ash content and the drying process of the 
extracted pectin, however, may reduce the solubility of pectin [47]. It has been 
shown too that a decrease in the esterified carboxylic group reduced the solubility 
of extracted pectin; this insolubility of the extracted pectin is probably due to the 
presence of electrolytes in de-methylated pectic acid [47]. Thus, pectins with lower 
DE are less hydrophilic [69].
Dilute pectin solutions are Newtonian in behavior but at a moderate concentra-
tion, they exhibit the non-Newtonian, pseudo plastic behavior characteristics. 
Solubility, viscosity, and gelation are generally related. Whatever factors increase 
gel strength will increase the gelling tendency, viscosity, decrease solubility, and 
vice versa [84].
3.5 Antioxidant activity
Another property of pectin that could affect its application is its antioxidant 
activity. However, there are limited studies to show how this property may be 
applied to either the food industry or the pharmaceutical sector [85].
Pectins
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4. Modifications of pectin for future applications
The presence of several hydroxyl and carboxyl groups distributed along its 
backbone as well as a certain amount of neutral sugars presented as side chains gives 
pectin the capability of producing a broad spectrum of derivatives with modified or 
new functional properties. Various methods used for pectin modification include 
substitution (alkylation, amidation, quaternization, thiolation, sulfation, oxida-
tion, etc.), chain elongation (cross-linking and grafting) and depolymerization 
(chemical, physical, and enzymatic degradation). Saponification (a process cata-
lyzed by mineral acids, bases, salts of weak acids and primary aliphatic amines) can 
also be used to modify pectin chemically. Modification induced by pH changes can 
produce new fragments that have their solubility and biological activities altered 
[86]. Enzymatic modification of pectin has been achieved by using endo-polygalac-
turonase (Endo-PG), resulting in highly selective and specific structural changes in 
the polymer backbone. This modification leads to the cleavage of glycosidic linkages 
between two non-esterified α-D-galacturonic acid residues inside the HG frag-
ment, which is depolymerisation. The enzymatic modification method can alter the 
macromolecular structure of pectin and can yield modified pectin with newer and 
improved properties and functionalities [87].
A new hydrolyzed polyacrylamide-graft-sodium alginate (PAAmg-SA) and 
diclofenac sodium-loaded interpenetrating polymer network (IPN) beads of pectin 
were developed using the ionic gelation method. The results of the investigation 
verified that hydrolyzed PAAm-g-SA and pectin cross-linked with aluminum ion 
(Al3+) and glutaraldehyde could form an optimal matrix material for the production 
of IPN beads to support the sustained release of diclofenac sodium [88]. In another 
study, for the nasal administration of tacrine hydrochloride (an anti-Alzheimer 
drug), mucoadhesive microparticles based on chitosan/pectin polyelectrolyte 
complexes were prepared. The microparticles were produced by spray drying fol-
lowed by lyophilization and direct spray drying. The study thus demonstrated the 
potential of the chitosan/pectin polyelectrolyte complexes to function variously in 
mucoadhesive microparticles [89, 90]. The chitosan/pectin molar ratio influenced 
the water uptake and tacrine hydrochloride permeation [90, 91].
Emerging advanced manufacturing technology in the field of tissue engineering 
and pharmaceutical formulations is the use of 3D bioprinting technology. 3D print-
ing is an additive manufacturing technology in which objects are constructed in a 
layer-by-layer manner achieved by heat fusion, ultraviolet light (UV), and chemi-
cal bonding [91]. Spritam®, a fast disintegrating orodispersible tablet containing 
levetiracetam for epilepsy was the first 3D printed drug product approved by the 
US Food and Drug Administration (FDA) in 2015 [91]. To sustain the manufactur-
ing of these types of drugs using this new technique, biomaterials that are green 
and non-toxic, derived from renewable sources and can be processed through 3D 
bioprinting are being developed [42, 60]. Common techniques include powder 
bed printing, vat polymerization (VP), and fused deposition modeling (FDM) 
[92]. A major disadvantage of the FDM technology is the need to insert printing 
materials into a nozzle in the form of a solid filament, which is non-existing for 
many pharmaceutical materials, thus necessitating the transformation of phar-
maceutical-grade materials, including active pharmaceutical ingredients (API), 
into FDM-suitable filaments using techniques like hot-melt extrusion (HME). 
However, thermolabile therapeutics are not suitable for extrusion via FDM, due 
to potential degradation concerns [93]. The use of bio-inks for extrusion-based 
bioprinting at room or body temperature has shown clinical potential in achieving 
personalized treatment [92]. For example, Long et al. developed a personalized 
3D printed wound dressing composed of chitosan and pectin with the ability to 
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control dimensional properties such as thickness and pore size using an extrusion-
based bioprinter [91, 92], while allowing for facile lidocaine incorporation for 
immediate pain relief [94]. Pectin from citrus peels has also been cross-linked with 
(3-glycidyloxypropyl)trimethoxysilane (GPTMS) through a one-pot procedure to 
obtain freeze-dried porous pectin sponges with varying porosity, water uptake, 
and compressive modulus [42]. The addition of GPTMS improved the printability 
of pectin due to an increase in viscosity and yield stress [95]. Without the use 
of any additional support material, three-dimensional woodpile and complex 
anatomical-shaped scaffolds interconnected with micro and macro pores were, 
therefore, bioprinted [96]. Thus showing the great potential of pectin cross-linked 
with GPTMS as biomaterial ink to fabricate patient-specific scaffolds that could be 
used to promote tissue regeneration in vivo [42]. In another study, gelatin, another 
natural biopolymer has had its rheological properties improved to aid its bio-
printing performance by using pectin as a rheology modifier of gelatin and GPTMS 
as a gelatin-pectin crosslinking agent [95]. Pectin played a key role in increasing 
the viscosity and the yield stress of low viscous gelatin solutions as shown through 
investigation of the rheological properties, as well as bioprinting assessments [96]. 
Water stable, three-dimensional, and self-supporting gelatin-pectin-GPTMS scaf-
folds with interconnected micro- and macro- porosity were successfully obtained 
by combining extrusion-based bioprinting and freeze-drying which did not require 
any additional temperature control to further modulate the rheological properties 
of gelatin solutions [95]. Patient-centric dosage forms have been produced through 
additive manufacturing techniques, which enable its design with precise control 
over dimension and microstructure, factors that are known to ultimately play key 
roles in modulating drug release kinetics, a feat not achieved through compression; 
traditional manufacturing techniques [92, 96, 97].
5. Conclusions
Pectin over the years has “metamorphosed” from just being a gelling agent for 
the production of jam and confectionaries to a biomaterial with health benefits 
to being useful as an excipient in drug delivery systems and more recently even 
personalized 3D printed medicine. This is as a result of a better understanding of its 
structure, mechanism by which it gels, and its properties such as degree of esterifi-
cation and degree of blockiness, which has aided its classification and application.
The pharmaceutical industry has a material that can be explored in different 
functional dimensions as the usefulness and functionality of pectin unfolds.
Conflict of interest




Olufunke D. Akin-Ajani* and Adenike Okunlola
Department of Pharmaceutics and Industrial Pharmacy, University of Ibadan, 
Ibadan, Nigeria
*Address all correspondence to: oakinajani@yahoo.com
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
11
Pharmaceutical Applications of Pectin
DOI: http://dx.doi.org/10.5772/intechopen.100152
References
[1] Nayak A, Olatunji O, Das DB, 
Vladvisavljevic G. Pharmaceutical 
Applications of Natural Polymers. 
Natural Polymers. 2015; 263-313|. DOI: 
10.1007/978-3-319-26414-1-9.
[2] Furrer P. The central role of 
excipients in drug formulation 





[3] Ogaji IJ, Nep EI, Peter JDA. Advances 
in natural polymers as pharmaceutical 
excipients. Pharm Anal Acta 
2011; 3:1-16.
[4] Robertson MI. Regulatory issues with 
excipients International Journal of 
Pharmaceutics. 1999; 187(2): 273-276. 
DOI: 10.1016/S0378-5173(99)00110-6
[5] Reddy SB, Ponnamma D, Choudhary 
R and Sadasivuni KK. A Comparative 
Review of Natural and Synthetic 
Biopolymer Composite Scaffolds. 
Polymers 2021, 13: 1105:1-51. DOI: 
10.3390/polym13071105.
[6] Kulkarni GT, Gowthamarajan K, 
Dhobe FY, Suresh B. Development of 
controlled release spheroids using 
natural polysaccharide as release 
modifier. Drug Deliv 2005; 12:201-206.
[7] Beneke CE, Viljoen AM, and 
Hamman JH. Polymeric Plant-derived 
Excipients in Drug Delivery. Molecules. 
2009; 14(7):2602-2620. DOI: 10.3390/
molecules14072602.
[8] Seki H, Tamura K, Muranaka T. 
Plant-derived isoprenoid sweeteners: 
recent progress in biosynthetic gene 
discovery and perspectives on microbial 
production. Biosci Biotechnol Biochem 
2018; 82(6):927-934.
[9] Okunlola A. Optimization of 
formulations of chloroquine phosphate 
tablets containing Ofada rice (Oryza 
glaberrina) starch as a binder: A Grey-
Taguchi analysis. J.Excip. Food. Chem 
2020; 11(3):62 – 75.
[10] Vervoort L, Van den Mooter G, 
Augustijns P, Busson R, Toppet S. Inulin 
hydrogels as carrier for colonic drug 
targeting: I. Synthesis and 
characterization of methacrylated inulin 
and hydrogel formation. Pharm Res. 
1997; 14: 1730-1736.
[11] Okunlola A and Adedeji AT. Cross-
linked plantain starch-urea as a polymer 
in matrix tablets of ambroxol 
hydrochloride. Br. J.Pharm. 2020; 5 (1): 
1- 13
[12] Odeku OA, Patani B. Evaluation of 
dika nut mucilage (Irvingia gabonensis) 
as a binding agent in metronidazole 
tablet formulation. Pharm Dev Technol 
2005; 10:439-446.
[13] Ndjouenkeu R, Akingbala J, 
Oguntimein G. Emulsifying properties 
of three African food hydrocolloids: 
Okra (Hibiscus esculentus), dika nut 
(Irvingia gabonensis) and khan 
(Belschmiedia sp.). Plant Foods Hum. 
Nutr. 1997;51:245-255
[14] Balasubramaniam J, Rao VU, 
Vasudha M, Babu J, Rajinikanth PS. 
Sodium alginate microspheres of 
metformin HCl: Formulation and in 
vitro evaluation. Curr Drug Deliv 2007; 
4:249-56.
[15] Santos H, Veiga F, Pina ME, 
Sousa JJ. Compaction compression and 
drug release properties of diclofenac 
sodium and ibuprofen pellets 
comprising xanthan gum as a sustained 
release agent. Int J Pharm. 2005; 
295:15-27.
[16] Cheng K, Lim LY. Insulin-loaded 
calcium pectinate nanoparticles: Effects 
of pectin molecular weight and 
Pectins
12
formulation pH. Drug Dev Ind Pharm 
2004; 30:359-367.
[17] Noreena A, Nazlic Z, Akrama J, 
Rasulb I, Manshaa A, Yaqoobc N, 
Iqbald R, Tabasuma S, Zubera M, 
Ziaa KM. Pectins functionalized 
biomaterials; a new viable approach for 
biomedical applications: A review. Int. 
J.Bio. Macromol 2017; 101: 254-272.
[18] Mohnen D. Pectin structure and 
biosynthesis. Curr. Opin.Plant Biol. 
2008; 11: 266-277.
[19] Okunlola, A. and Akindele, L.O. 
Application of response surface 
methodology and central composite 
design for the optimization of 
metformin microsphere formulations 
using tangerine (citrus tangerina) 
pectin as copolymer. Br.J.Pharm. Res. 
2016; 11(3): 1 - 14
[20] Rolin C, Pectin, In: Industrial gums, 
RL Whistler and JN BeMiller (eds), 
1993, 3rd eds. New York: Academic  
Press
[21] Andarwulan N, Faridah DN, 
Prabekti YS, Fadhilatunnur H, 
Mualim L, Aziz SA, Cisneros-Zevallos L. 
Dietary Fiber Content of Waterleaf 
(Talinum triangulare (Jacq.) Willd) 
Cultivated with Organic and 
Conventional Fertilization in Different 
Seasons. American Journal of Plant 
Sciences, 2015; 6:334-343. DOI:10.4236/
ajps.2015.62038
[22] Priyangini F, Walde SG, 
Chidambaram R. Extraction 
optimization of pectin from cocoa pod 
husks (Theobroma cacao L.) with 
ascorbic acid using response surface 
methodology. Carbohydr. Polym 2018; 
202:497-503. DOI: 10.1016/j.
carbpol.2018.08.103.
[23] Yang JS, Mu TH, Ma M. Extraction, 
structure and emulsifying properties of 
pectin from potato pulp. Food Chem. 
2018; 244: 197 – 205.
[24] Hoff HE, Castro MD. Chemical 
composition of the potato cell wall. J. 
Agric. Food Chem. 1969; 17: 1328-1331.
[25] May CD, Handbook of 
Hydrocolloids, in: P.A. Williams, G.O. 
Phillips (Eds.),Woodhead Publishing 
Limited, Cambridge, UK, 2003, p. 
169-188.
[26] Scheller HV, Jensen JK, 
Sørensen SO, Harholt J, Geshi N. 
Biosynthesis of pectin Physiol. Plant. 
2007; 129:283-295.
[27] Sriamornsak JP. Application of 
pectin in oral drug delivery. Expert 
Opin. Drug Deliv. 2011; 8:1009-1023.
[28] Perez, S., Rodriguez-Carvajal MA, 
Doco T. Doco, A complex plant cell wall 
polysaccharide: rhamnogalacturonan II. 
A structure in quest of a function. 
Biochimie 2003; 85: 109-121.
[29] Oakenfull, A. Scott, J (1984). 
Hydrophobic interaction in the gelation 
of high methoxy pectins. Food Sci. 
1984; 49:1093-1098
[30] Raeisi F, Raeisi E. Mini review of 
polysaccharide nanoparticles and drug 
delivery process. Advances in Applied 
NanoBio-Technologie. 2020; 1(2):
[31] Rolin C, Pectins and their 
manipulation, in: C. Seymour, P. Knox 
(Eds.), Commercial Pectins 
Preparation. Oxford Blackwell Boca 
Raton FL; 2002. p. 222-241.
[32] Slany J. Evaluation of tablets  
with pectin as a binding agent. 
Farmaceuticky Obzor, 1981a;50:  
491 – 498.
[33] Slany J et. al. Study of functional 
action of citrus pectins in tablets. Ceska 
a Slovenska Farmacie, 1981b; 30: 
195-200.
[34] Krusteva S, Lambov N, Velinov G. 
Pharmaceutical investigation of a 
13
Pharmaceutical Applications of Pectin
DOI: http://dx.doi.org/10.5772/intechopen.100152
bioerodible nystatin system. Pharmazie. 
1990; 45:195-197.
[35] Naggar VF, El-Khawas M, Ismail FA, 
Boraie NA. Pectin, a possible matrix for 
oral sustained-release preparations of 
water-soluble drugs. STP Pharma Sci. 
1992; 2:227-234.
[36] Srisagul Sungthongjeen, Pornsak 
Sriamornsak, Tasana Pitaksuteepong, 
Atawit Somsiri, and Satit 
Puttipipatkhachorn. Effect of degree of 
esterification of pectin and calcium 
amount on drug release from pectin-
based matrix tablets. AAPS 
PharmSciTech 2004; 5(1) Article 9 
(http://www.aapspharmscitech.org).
[37] Aydin Z, Akbuga J. Preparation and 
evaluation of pectin beads. Int JPharm 
1996; 137: 133-136.
[38] Sriamornsak P. Chemistry of pectin 
and its pharmaceutical use: A review. 
Silpakorn University International 
Journal 2003; 3(1-2): 206-228.
[39] Wicker, L., Kim, Y., Kim M. J. 
Thirkield, B. Lin, Z. and Jung, J. Pectin 
as a bioactive polysaccharide—
Extracting tailored function from less. 
Food Hydrocoll. 2014; 42:251-259.
[40] Oakenfull, D.G. The chemistry of 
high-methoxyl pectins. In: The 
chemistry and technology of pectin, ed. 
R.H. Walter. New York: Academic 
Press; 1991
[41] Sundar Raj AA, Rubila S, 
Jayabalan R, Ranganathan TV. (2012). A 
review on pectin: Chemistry due to 
general properties of pectin and 
pharmaceutical uses. Scientific reports, 
1: 2, 1-4.
[42] Kaur A and Kaur G. Mucoadhesive 
buccal patches based on interpolymer 
complexes of chitosan–pectin for 
delivery of carvedilol. Saudi Pharm J. 
2012; 20(1): 21-27. DOI: 10.1016/j.
jsps.2011.04.005
[43] Srivastav P and Malviya R. Sources 
of pectin, extraction and its application 
in pharmaceutical industry – An 
overview. Indian J.Nat. Prod.Resour 
2011; 2(1): 10 -18
[44] Mishra RK, Majeed, BA and Banthia 
AK Development and characterization 
of pectin/gelatin hydrogel membranes 
for wound dressing. Int.J.Plast. Technol. 
2011; 15(1): 82-95.
[45] Leroux J, Langendorff V, Schick G, 
Vaishnav V, Mazoyer J. Emulsion 
stabilizing properties of pectin. Food 
Hydrocoll. 2003; 17(4): 455 – 462.
[46] Dickinson, E. Hydrocolloids at 
interfaces and the influence on the 
properties of dispersed systems. Food 
Hydrocolloids, 2003; 17(1):25-39.
[47] Celus M, Kyomugasho C, Van 
Loey AM, Grauwet T, Hendrickx ME. 
Influence of pectin structural properties 
on interactions with divalent cations 
and its associated functionalities. 
Compr. Rev. Food Sci. Food Saf. 2018; 
17: 1576 – 1594. DOI: 
10.1111/1541-4337.12394
[48] Cervantes-Paz B, Ornelas-Paz J, de 
J, Ruiz-Cruz S, Rios-Velasco C, 
Ibarra-Junquera V, Gardea-Bejar AA. 
Effects of pectin on lipid ´ digestion and 
possible implications for carotenoid 
bioavailability during pre-absorptive 
stages: A review. Food Res. Int. 2017; 
99:917-927.
[49] Schwartz SE, Levine RA, Singh A, 
Scheidecker JR, Track NS. Sustained 
pectin ingestion delays gastric 
emptying. Gastroenterology. 1982; 
83(4):812-817.
[50] Wicker L, Kim Y. Pectin and health. 
in Encyclopedia of Food and Health, 
2016; 289-293. https://doi.org/10.1016/
B978-0-12-384947-2.00532-8
[51] Jackson CL, Dreaden TM, 
Theobald LK, Tran NM, Beal TL, Eid M, 
Pectins
14
Gao MY, Shirley RB, Stoffel MT, 
Kumar MV, Mohnen D. 2007. Pectin 
Induces Apoptosis in Human Prostate 
Cancer Cells: Correlation of Apoptotic 
Function with Pectin Structure. 
Glycobiology. 2007; 17:805-819.
[52] Behall K, Reiser S. Effects of Pectin 
on Human Metabolism, in “Chemistry 
and Functions of Pectins”. In: Fishman, 
M.L., Ren, J.J. (Eds.).American 
Chemical Society, Washington, DC. 
1986:p. 248-265.
[53] Brown L, Rosner B, Willett WW, 
Sacks FM. Cholesterol-Lowering Effects 
of Dietary Fiber: A Meta-Analysis. Am.J. 
Clin.Nutri. 1999; 69:30-42.
[54] Inngjerdingen KT, Patel TR, 
Chen X, Kenne L, Allen S, Morris GA., 
et al. Immunological and Structural 
Properties of a Pectic Polymer from 
Glinus oppositifolius. Glycobiology 2007; 
17:1299-1310.
[55] Begum R, Azizb MG, Uddinb MB, 
Yusof YA. Characterization of Jackfruit 
(Artocarpus heterophyllus) Waste Pectin 
as Influenced by Various Extraction 
Conditions. Agriculture and 
Agricultural Science Procedia. 2014; 
2:244 – 251.
[56] Braudo EE, Danilova IV, 
Dianova VT, Kobak VV, Plashchina IG, 
Sidorov EV, Bogatyrev AN. 
Thermodynamic approach to the 
selection of polyuronide sequestrants 
for preventive and medicinal nutrition. 
Die Nahrung, 1996; 40:205-208.
[57] Eliaz I, Hotchkiss AT, Fishman ML, 
Rode D. The effect of modified citrus 
pectin on urinary excretion of toxic 
elements. Phytotherapy Res. 2006; 
20:859-864.
[58] Zhao ZY, Liang L, Fan X, Yu Z, 
Hotchkiss AT, Wilk BJ, Eliaz I. The role 
of modified citrus pectin as an effective 
chelator of lead in children hospitalized 
with toxic lead levels. Alternative 
Therapies. 2008; 14:34-38.
[59] Pe’rez-Martı’nez JD, Sa’nchez- 
Becerril M, Ornelas-Paz JJ, Gonza’lez-
Cha’vez MM, Ibarra-Junquera V, Escalante- 
Minakata P. The effect of extraction 
conditions on the chemical 
characteristics of pectin from opuntia 
Ficus indica cladode flour. J Polym 
Environ. 2013; 21: 1040 – 1051. DOI: 
10.1007/s10924-013-0602-2
[60] Lapomarda A, De Acutis D Chiesa I, 
Fortunato GM, Montemurro F, De 
Maria C, Belmonte MM , Gottardi R, 
Vozzi G. Pectin-GPTMS-Based 
Biomaterial: toward a sustainable 




[61] Mukhiddinov Z.K., Khalikov DK, 
Abdusamiev F.T., Avloev C.C. Isolation 
and structural characterization of a 
pectin homo and rhamnogalacturonan. 
Talanta 2000; 53: 171-176.
[62] Presentato A, Piacenza E, Scurria A, 
Albanese L, Zabini F, Meneguzzo F, 
Nuzzo D, Pagliaro M, Martino DC, 
Alduina R, Ciriminna R. A New Water-
Soluble Bactericidal Agent for the 
Treatment of Infections Caused by 
Gram-Positive and Gram-Negative 
Bacterial Strains. Antibiotics. 2020; 9: 
586; DOI:10.3390/antibiotics9090586
[63] Morra M, Cassinelli C, Cascardo G, 
Nagel MD, Volpe CD, Siboni S, 
Maniglio D, Brugnara M, Ceccone G, 
Schols HA, Ulvskov P. Effects on 
Interfacial Properties and Cell Adhesion 
of Surface Modification by Pectic Hairy 
Regions. Biomacromolecules. 2004; 5: 
2094-2104.
[64] Ciriminna R, Fidalgo A, Delisi R, 
Tamburino A, Carnaroglio D, 
Cravotto G, Ilharco LM, Pagliaro M. 
Controlling the Degree of Esterification 
of Citrus Pectin for Demanding 
Applications by Selection of the Source 
ACS Omega 2017; 2:7991-7995 DOI: 
10.1021/acsomega.7b01109
15
Pharmaceutical Applications of Pectin
DOI: http://dx.doi.org/10.5772/intechopen.100152
[65] Harding SE, Tombs MP, Adams GG, 
Paulsen BS, Inngjerdingen KT, 
Barsett H. An Introduction to 
Polysaccharide Biotechnology; CRC 
Press: Boca Raton, FL, 2017; p 99-126.
[66] Bagherian H, Zokaee Ashtiani F, 
Fouladitajar A, Mohtashamy M. 
Comparisons between conventional, 
microwave- and ultrasound-assisted 
methods for extraction of pectin from 
grapefruit. Chem Eng Process Process 
Intensif. Elsevier B.V.; 2011; 50: 1237-
1243. DOI: 10.1016/j.cep.2011.08.002
[67] Brain C, Jhonston B. Spreabale 
honey, US patents, 4,532,143. [Internet]. 
US 4532143 A, 1985. p. US patents, 
4,532,143 (1985). Available: http://www.
lens.org/lens/patent/US_4532143_A/
fulltext
[68] Sayah MY, Chabir R, Benyahia H, 
Rodi Kandri Y, Ouazzani Chahdi F, 
Touzani H, et al. Yield, Esterification 
Degree and Molecular Weight 
Evaluation of Pectins Isolated from 
Orange and Grapefruit Peels under 
Different Conditions. PLoS ONE 2016; 
11(9): e0161751. doi:10.1371/journal. 
pone.0161751
[69] Yavuz-Düzgün M, Zeeb B, Dreher J, 
Özçelik B, Weiss J. The Impact of 
Esterification Degree and Source of 
Pectins on Complex Coacervation as a 
Tool to Mask the Bitterness of Potato 
Protein Isolates. Food Biophysics 2020; 
15:376-385. DOI:10.1007/
s11483-020-09631-1
[70] Ralet MC, Dronnet V, Buchholt HC, 
Thibault JF. Enzymatically and 
chemically de-esterified lime pectins: 
Characterisation, polyelectrolyte 
behaviour and calcium-binding 
properties. Carbohydr, Res., 2001; 
336:117-125.
[71] Thibault JF, Rinaudo M. Interactions 
of mono- and divalent counterions with 
alkali- and enzyme-deesterified pectins 
in salt-free solutions. Biopolymers, 
1985; 24:2131-2143.
[72] Vincken JP, Schols HA, Oomen RJFJ, 
Beldman G, Visser RGF, Voragen AGJ. 
Pectin- The hairy thing. Evidence that 
homogalacturonan is a side chain of 
rhamnogalacturonan I. In AGJ Voragen, 
HA Schols, R Visser (Eds.), Advances in 
pectin and pectinases research. 
Dordrecht, The Netherlands: Kluwer 
Academic Publishers 2003a; p.47-59.
[73] Cameron RG, Kim Y, Galant AL, 
Luzio GA, Tzen JTC. Pectin 
homogalacturonans: Nanostructural 
characterization of methyl esterified 
domains. Food Hydrocoll. 2015; 
47:184-190.
[74] Daas PJH, Meyer-Hansen K, Schols, 
HA, De Ruiter GA, Voragen AGJ. 
Investigation of the non-esterified 
galacturonic acid distribution in pectin 
with endopolygalacturonase. 
Carbohydrate Research. 1999; 
318:135-145.
[75] Guillotin SE, Bakx EJ, Boulenguer P, 
Mazoyer J, Schols HA, Voragen, AGJ. 
Populations having different GalA 
blocks characteristics are present in 
commercial pectins, which are 
chemically similar but have different 
functionalities. Carbohydr. Polym. 
2005; 60:391-398.
[76] Grant GT, Morris ER, Rees DA, 
Smith PJC, Thom D. Biological 
interactions between polysaccharides 
and divalent cations: The egg-box 
model. FEBS Letters, 1973; 32:195-198.
[77] Assifaoui A, Lerbret A, Uyen HTD, 
Neiers F, Chambin O, Loupiac C, 
Cousin F. Structural behaviour 
differences in low methoxy pectin 
solutions in the presence of divalent 
cations (Ca2+ and Zn2+): A process 
driven by the binding mechanism of the 




[78] Fraeye I, Doungla E, Duvetter T, 
Moldenaers P, Van Loey A, 
Hendrickx M. Influence of intrinsic and 
extrinsic factors on the rheology of 
pectin-calcium gels. Food Hydrocoll. 
2009; 23:2069-2077.
[79] Kyomugasho C, Christiaens S, Van 
de Walle D, Van Loey AM, 
Dewettinck K, Hendrickx ME. 
Evaluation of cation-facilitated pectin-
gel properties: Cryo-SEM visualisation 
and rheological properties. Food 
Hydrocoll. 2016; 61:172-182.
[80] Azad AKM, Ali MA, Sorifa Akter S, 
Jiaur Rahman I, Ahmed MIsolation and 
characterization of pectin extracted 
from lemon pomace during ripening 
Journal of Food and Nutrition Sciences 
2014; 2(2): 30-35 DOI: 10.11648/j.
jfns.20140202.12
[81] Ismail NSM, Ramli N, Hani NM, 
Meon Z. Extraction and characterization 
of pectin from dragon fruit (Hylocereus 
polyrhizus) using various extraction 
conditions. Sains Malaysiana. 2012; 
41: 41-45.
[82] Madhav, A., Pushpalatha, P.B. 
Characterization of pectin extracted 
from different fruit wastes. Int J Trop 
Agric. 2002; 40: 53-55.
[83] Cagatay Ceylan, Oguz Bayraktar, 
Erhan Atci, Şahin Sarrafi Extraction and 
characterization of pectin from fresh 
globe artichoke and canned artichoke 
waste. GIDA 2017; 42 (5): 568-576 DOI: 
10.15237/gida.GD17015
[84] Hercules Incorporated. Food gum 
products description: General 
description of pectin. 1999
[85] Sundar Raj AA, Rubila S, 
Jayabalan R, Ranganathan TV. .A review 
on pectin: Chemistry due to general 
properties of pectin and pharmaceutical 
uses. Scientific reports, 2012; 1: 2, 1-4.
[86] Nguyen MBN, Pirak T. 
Physicochemical properties and 
antioxidant activities of white dragon 
fruit peel pectin extracted with 
conventional and ultrasound-assisted 
extraction, Cogent Food & Agriculture, 
2019; 5:1, 1633076, DOI:10.1080/233119
32.2019.1633076
[87] Zhang W, Xu P, Zhang H. Pectin in 
cancer therapy: A review. Trends Food 
Sci. Technol. 2015; 44: 258-271.
[88] Karaki N, Aljawish A, Humeau C, 
Muniglia L, Jasniewski J. Enzymatic 
modification of polysaccharides: 
Mechanisms, properties, and potential 
applications: A review. Enzyme Microb. 
Technol. 2016; 90:1-18.
[89] Giri T.K., Thakur D., Alexander A., 
Ajazuddin, Badwaik H., Tripathy M., 
Tripathi D.K. Biodegradable IPN 
hydrogel beads of pectin and grafted 
alginate for controlled delivery of 
diclofenac sodium. J. Mater. Sci. Mater. 
Med. 2013; 24:1179-1190. DOI: 10.1007/
s10856-013-4884-7.
[90] Minzanova ST, Mironov VF, 
Arkhipova DM, Khabibullina AV, 
Mironova LG, Zakirova YM, 
Milyukov VA. Biological Activity and 
Pharmacological Application of Pectic 
Polysaccharides: A Review. Polymers 
2018;10:1407; doi:10.3390/
polym10121407 31
[91] Saladini B., Bigucci F., Cerchiara T., 
Gallucci M.C., Luppi B. Microparticles 
based on chitosan/pectin polyelectrolyte 
complexes for nasal delivery of tacrine 
hydrochloride. Drug Delivery Transl. 
Res. 2013; 3:33-41. DOI: 10.1007/
s13346-012-0086-y
[92] Ivone R, Yang Yand Jie Shen J 
(2021). Recent Advances in 3D Printing 
for Parenteral ApplicationsThe AAPS 
Journal 2021; 23:87. DOI: 10.1208/
s12248-021-00610-z.
17
Pharmaceutical Applications of Pectin
DOI: http://dx.doi.org/10.5772/intechopen.100152
[93] Azad MA, Olawuni D, Kimbell G, 
Badruddoza AZM, Hossain MS, 
Sultana T. Polymers for extrusion-based 
3D printing of pharmaceuticals: a 
holistic materials–process perspective. 
Pharmaceutics. 2020; 12:1-34.
[94] Araújo MRP, Sa-Barreto LL, 
Gratieri T, Gelfuso GM, Cunha-Filho M. 
The digital pharmacies era: how 3D 
printing technology using fused 
deposition modelling can become a 
reality. Pharmaceutics. 2019;11:3
[95] Long J, Etxeberria AE, Nand AV, 
Bunt CR, Ray S, Seyfoddin A. A 3D 
printed chitosan-pectin hydrogel wound 
dressing for lidocaine hydrochloride 
delivery. Mater Sci Eng C [Internet]. 
2019; 104:109873. Available from. 
https://doi.org/10.1016/j.
msec.2019.109873.
[96] Lapomarda A, Pulidori E, 
Cerqueni G, Chiesa I, DeBlasiM, MA, 
Montemurro F, Duce C, Belmonte M, 
Tiné MR, Vozzi G, De Maria C. Pectin as 
Rheology Modifier of a Gelatin-Based 
Biomaterial Ink. Materials 2021; 
14(11): 1-16.
[97] Mathew E, Pitzanti G, Larrañeta E, 
Lamprou DA. Three-dimensional 
printing of pharmaceuticals and drug 
delivery devices. Pharmaceutics. 2020; 
12(3):1-9.
